The Cooper Companies, Inc. (COO)

AI-powered earnings prediction for The Cooper Companies, Inc. (COO).

84.07
+0.47%
USD, 2 days ago
Market Cap
16.76B
Google

Company Overview

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Phone
925 460 3600
Headquarters
6101 Bollinger Canyon Road
San Ramon, CA, 94583
United States
Full-Time Employees
15,000

Key Metrics

P/E Ratio (TTM)
45.07
Forward P/E
17.01
Price to Book
2.00
Beta
1.03
Profit Margin
9.16%
Gross Margin
65.54%
Return on Equity
4.59%
Return on Assets
3.47%
Earnings Growth
-28.20%
Revenue Growth
4.60%

Financial Health

Total Cash
$110.60M
Total Debt
$2.78B
Debt to Equity
33.79
Current Ratio
1.89
Free Cash Flow
$376.59M
Operating Cash Flow
$796.10M

Analyst Recommendations

Target Price (Mean)
$91.00
Target High
$100.00
Target Low
$73.00
Recommendation
buy
Analyst Coverage
16 Analysts

Trading Ideas

Related Stocks